![](/img/cover-not-exists.png)
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations
Kim, Dong-Wan, Lee, Se-Hoon, Lee, Jong Seok, Lee, Myung Ah, Kang, Jin Hyoung, Kim, Si Young, Shin, Sang Won, Kim, Hoon-Kyo, Heo, Dae SeogVolume:
71
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2010.04.005
Date:
January, 2011
File:
PDF, 433 KB
english, 2011